Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VERACYTE, INC. Director's Dealing 2020

Jul 27, 2020

31551_dirs_2020-07-27_9bb760c1-011d-4523-adc3-26b20464e6f8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: VERACYTE, INC. (VCYT)
CIK: 0001384101
Period of Report: 2020-07-20

Reporting Person: Anderson Bonnie H (Director, Chairman and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-07-20 Common Stock M 1853 $4 Acquired 274060 Direct
2020-07-20 Common Stock M 18496 $8.86 Acquired 292556 Direct
2020-07-20 Common Stock S 20349 $32.0365 Disposed 272207 Direct
2020-07-21 Common Stock M 3447 $8.86 Acquired 275654 Direct
2020-07-21 Common Stock S 3447 $32.0898 Disposed 272207 Direct
2020-07-22 Common Stock M 100 $8.86 Acquired 272307 Direct
2020-07-22 Common Stock S 100 $32 Disposed 272207 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-07-20 Stock Option (right to buy) $4 M 1853 Disposed 2023-02-04 Common Stock (1853) Direct
2020-07-20 Stock Option (right to buy) $8.86 M 18496 Disposed 2025-03-02 Common Stock (18496) Direct
2020-07-21 Stock Option (right to buy) $8.86 M 3447 Disposed 2025-03-02 Common Stock (3447) Direct
2020-07-22 Stock Option (right to buy) $8.86 M 100 Disposed 2025-03-02 Common Stock (100) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 99085 Indirect

Footnotes

F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019.

F2: Represents weighted average sales price. Sale prices for the transactions range from $32.00 to $32.34. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

F3: Represents weighted average sales price. Sale prices for the transactions range from $32.00 to $32.25. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

F4: The option is fully vested.

F5: On February 5, 2013, the Reporting Person was issued 3 stock options which have different vesting dates, all of which are vested. These options include: (1) 112,500, of which 25,000 options remain, (2) 12,500, of which none remain and (3) 24,112, of which 1,853 were exercised on 07/20/2020 and none remain.

F6: The total reported in Column 9 has been adjusted to correct an understatement of total holdings by 98,438 shares as reflected in Form 4 filed on July 22, 2020.